Showing results (1031-1040 of 1,427) with videos related to

Sort By:
Pageof 143
Physical Chemistry Chemical Physics : PCCP|April 16, 2026
Rational engineering of Cu-BTC/Al<sub>2</sub>S<sub>3</sub>@PPy with improved charge transport and interfacial properties for energy storage and the hydrogen evolution reactionMuhammad Ashraf, Afaf Khadr Alqorashi, M Waqas Iqbal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
A phase 1 study of mapatumumab (fully human monoclonal antibody to TRAIL-R1) in patients with advanced solid malignanciesSébastien J Hotte, Hal W Hirte, Eric X Chen, et al.
Gynecologic Oncology|May 23, 2013
The strong prognostic value of KELIM, a model-based parameter from CA 125 kinetics in ovarian cancer: data from CALYPSO trial (a GINECO-GCIG study)Benoit You, Olivier Colomban, Mark Heywood, et al.
Chemistry & Biology|August 28, 2012
Glucocorticoid compounds modify smoothened localization and hedgehog pathway activityYu Wang, Lance Davidow, Anthony C Arvanites, et al.
The Lancet. Oncology|February 2, 2015
Outcomes and endpoints in cancer trials: bridging the divideMichelle K Wilson, Deborah Collyar, Diana T Chingos, et al.
European Journal of Cancer (Oxford, England : 1990)|March 23, 2010
Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumoursHelen J Mackay, Hal Hirte, Terrence Colgan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 10, 2020
Low junctional adhesion molecule-A expression is associated with an epithelial to mesenchymal transition and poorer outcomes in high-grade serous carcinoma of uterine adnexaLaudine Communal, Mauricio Medrano, Fabrice Sircoulomb, et al.
JCO Precision Oncology|October 5, 2023
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian CancerLinda R Duska, Dmitriy Zamarin, Erica Hamilton, et al.
Biochemistry|December 10, 1999
Characterization of unique DNA-binding and transcriptional-activation functions in the carboxyl-terminal extension of the zinc finger region in the human vitamin D receptorJ C Hsieh, G K Whitfield, A K Oza, et al.
American Journal of Clinical Oncology|December 18, 1998
Phase I-II study of 5-fluorouracil, leucovorin, doxorubicin, methotrexate, and long-term oral etoposide (FLAME) in unresectable or metastatic gastric cancerG A Bjarnason, C Cripps, R Goel, et al.
Pageof 143